Your browser doesn't support javascript.
loading
Immune checkpoint inhibitors in endometrial cancer.
Gómez-Raposo, C; Merino Salvador, M; Aguayo Zamora, C; García de Santiago, B; Casado Sáenz, E.
Afiliação
  • Gómez-Raposo C; Department of Medical Oncology, Infanta Sofía University Hospital, Infanta Sofía and Henares Hospitals Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), Madrid, Spain; Molecular Oncology and Nutritional Genomics of Cancer, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, 28049, Spain. E
  • Merino Salvador M; Department of Medical Oncology, Infanta Sofía University Hospital, Infanta Sofía and Henares Hospitals Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), Madrid, Spain.
  • Aguayo Zamora C; Department of Medical Oncology, Infanta Sofía University Hospital, Infanta Sofía and Henares Hospitals Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), Madrid, Spain.
  • García de Santiago B; Department of Pharmacy, Infanta Sofía University Hospital, Infanta Sofía and Henares Hospitals Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), Madrid, Spain.
  • Casado Sáenz E; Department of Medical Oncology, Infanta Sofía University Hospital, Infanta Sofía and Henares Hospitals Foundation for Biomedical Research and Innovation (FIIB HUIS HHEN), Madrid, Spain; Molecular Oncology and Nutritional Genomics of Cancer, IMDEA-Food Institute, CEI UAM+CSIC, Madrid, 28049, Spain.
Crit Rev Oncol Hematol ; 161: 103306, 2021 May.
Article em En | MEDLINE | ID: mdl-33839243

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Inibidores de Checkpoint Imunológico Idioma: En Ano de publicação: 2021 Tipo de documento: Article